Intentar ORO - Gratis

Transforming Diagnostics and Personalized Medicine Amidst Challenges

The Business Guardian

|

December 29, 2024

Genomic testing, an advanced diagnostic tool, delves deep into the analysis of DNA, RNA, and proteomics to uncover genetic mutations, assess disease risks, and provide critical insights for medical decisions.

- CORRESPONDENT NEW DELHI

Transforming Diagnostics and Personalized Medicine Amidst Challenges

The field has seen transformative progress with the advent of technologies like next-generation sequencing, enabling the early detection of diseases, particularly cancers.

This cutting-edge approach has significantly enhanced diagnostic precision, making it a cornerstone in personalized medicine. However, challenges persist. Restricted insurance coverage, high costs, and the complexity of interpreting vast genomic data continue to hinder its widespread adoption.

These obstacles underscore the need for robust frameworks to ensure accessibility and affordability.

To shed light on this evolving field and its implications for healthcare, we turn to Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare Limited.

Q: What is genomic testing, and how does it differ from traditional diagnostic tests?

A: In 2003, the Human Genome Project that mapped an understanding of all human genes was completed and changed the entire testing scope impacting every clinical segment. Although genetic testing started way back in 1950 when Down (trisomy 21) and other syndromes were diagnosed by cytogenetic methods & evolved further in 1990s when the novel technique of PCR accelerated molecular genetic testing by enabling targeted testing for known pathogenic variants, it accelerated only when Next Generation Sequencing & other newer technologies added to the understanding of the human genome and its impact on disease.

Testing has now evolved from comprehensive gene panels to exome and genome sequencing as routine tests, thereby revolutionizing the diagnosis of rare genetic diseases among others.

As compared to traditional lab tests, genomic tests that study DNA, RNA, proteomics can identify mutations in our genes indicating if we have or not a genetic condition while also identifying our risk for developing a certain condition or passing on a genetic disorder to the next generation.

MÁS HISTORIAS DE The Business Guardian

The Business Guardian

The Business Guardian

INDIA RETAIL INFLATION TO AVERAGE 2.5% IN 2025-26 FISCAL

As the base effect on food fades, headline Consumer Price Index or retail inflation is likely to edge up slightly to average at 2.5 per cent this financial year 2025-26, Crisil has asserted.

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

Sense of relief: Zubeen's uncle on SIT charge-sheet

CHARGE-SHEET FILED

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

Nvidia eyes higher H200 chip output

Nvidia has told Chinese clients it is evaluating adding production capacity for its powerful H200 AI chips after orders exceeded its current output level, according to two sources briefed on the matter.

time to read

1 min

December 14, 2025

The Business Guardian

The Business Guardian

TARIFFS HAVE COST EACH U.S. HOUSEHOLD $1,200

Sweeping taxes on imports have cost the average American household nearly $1,200 since Donald Trump returned to the White House this year, according to calculations by Democrats on Congress’ Joint Economic Committee.

time to read

2 mins

December 14, 2025

The Business Guardian

The Business Guardian

CTA APPARELS HAILS INDIA-EU FTA PROGRESS

Indian garment manufacturer CTA Apparels has applauded the Government of India's encouraging progress on the India-EU Free Trade Agreement (FTA), with the blueprint now in advanced stages.

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

Shiprocket files updated IPO papers, eyes Rs 2,342 cr issue

Temasek-backed e-commerce enablement platform Shiprocket has filed updated draft papers with markets regulator Sebi to raise a little over Rs 2,342 crore through its initial public offering (IPO).

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

Azul gets court nod; US airlines to invest

A U.S. bankruptcy judge on Friday approved Azul's debt restructuring, allowing the Brazilian airline to slash more than $2 billion in debt and raise capital through a new equity rights offering and investment from American Airlines and United Airlines.

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

SC refuses to entertain bail plea in Mumbai BMW hit-and-run case

The Supreme Court has refused to entertain the bail plea of Mihir Shah, the son of a former Shiv Sena leader, in the 2024 Mumbai BMW hit-and-run case, saying “these boys need to be taught a lesson”.

time to read

1 mins

December 14, 2025

The Business Guardian

The Business Guardian

HOW TO USE YOUR BODY WEIGHT TO GYM AT HOME TO STAY FIT

Gyms also carry risks such as equipment-related injuries, overexertion, slips and falls, hygiene issues, and poor ventilation.

time to read

5 mins

December 14, 2025

The Business Guardian

Huawei phone packs upgraded China chip

The Kirin 9030, the chip that powers Huawei Technologies' latest flagship Mate 80 series handset, has been manufactured by China's top foundry SMIC with an improved version of 7 nanometres, which is still behind TSMC and Samsung, Canadian research firm TechInsights said.

time to read

1 min

December 14, 2025

Listen

Translate

Share

-
+

Change font size